Table 1 Study characteristics
# | Data Element | Frequency | Percentage |
|---|---|---|---|
1 | Study design (n = 41) | ||
Randomized Controlled Trial | 27 | 65.85% | |
Quasi-experimental Study | 2 | 4.88% | |
Analytical Cross-sectional Study | 4 | 9.76% | |
Observational Quantitative Study | 7 | 17.07% | |
Observational Mixed-Method Study | 1 | 2.44% | |
Total | 41 | 100% | |
2 | Targeted population (n = 41) | ||
General Adult Patients | 9 | 21.95% | |
Pediatric Patients | 6 | 14.63% | |
Pregnant Women | 2 | 4.88% | |
Patients with Chronic Disease or Mental Health Conditions | 16 | 39.02% | |
High-risk for Healthcare Utilization | 8 | 19.51% | |
Total | 41 | 100% | |
3 | Setting (n = 41) | ||
Rural | 4 | 9.76% | |
Urban | 28 | 68.30% | |
Regional or State-level or Multiple Regions | 9 | 21.95% | |
Total | 41 | 100% | |
4 | Funding source of study (n = 41) | ||
National Institutes for Health (NIH) | 9 | 21.95% | |
Centers for Medicare & Medicaid Services (CMS) | 2 | 4.88% | |
Other Federal or Non-federal Funding Source | 13 | 31.71% | |
Multiple Funding Sources | 10 | 24.30% | |
Private Funding Source | 1 | 2.44% | |
No External Funding | 3 | 7.32% | |
Not Described | 3 | 7.32% | |
Total | 41 | 100% | |